Modern Rheumatology Journal,
Год журнала:
2024,
Номер
18(2), С. 103 - 110
Опубликована: Апрель 22, 2024
Osteoporosis
(OP)
is
a
common
disease
leading
to
low-trauma
fractures
and
serious
medical
social
problem.
Often
fracture
the
first
clinical
manifestation
of
OP
that
has
been
asymptomatic
for
long
time,
necessitating
development
methods
early
detection
risk
assessment
this
disease.
multifactorial
with
strong
hereditary
component.
However,
as
data
from
study
genetic
factors
show,
only
15%
heritability
trait
can
be
explained.
In
context,
focus
research
shifting
area
epigenetic
regulation,
which
controls
gene
activity
without
altering
primary
structure
DNA.
One
most
promising
mechanisms
control
methylation,
affects
DNA
well
RNA
histones.
The
characteristics
these
possibilities
their
use
diagnosis
treatment
are
presented
in
review.
Cell Death Discovery,
Год журнала:
2024,
Номер
10(1)
Опубликована: Март 27, 2024
Abstract
Senile
osteoporosis
is
mainly
caused
by
osteoblasts
attenuation,
which
results
in
reduced
bone
mass
and
disrupted
remodeling.
Numerous
studies
have
focused
on
the
regulatory
role
of
m6A
modification
osteoporosis;
however,
most
investigated
differentiation
marrow
mesenchymal
stem
cells
(BMSCs),
while
direct
mechanism
remains
unknown.
This
study
revealed
that
progression
senile
closely
related
to
downregulation
methyltransferase-like
3
(METTL3).
Overexpression
METTL3
inhibits
osteoblast
aging.
Methylated
RNA
immunoprecipitation
sequencing
(MeRIP-seq)
upregulates
stability
Hspa1a
mRNA,
thereby
inhibiting
Moreover,
demonstrated
enhances
mRNA
via
regulate
Notably,
YTH
N6-methyladenosine
binding
protein
2
(YTHDF2)
participates
stabilizing
METTL3-mediated
process,
rather
than
well-known
degradation
function.
Mechanistically,
increases
a
YTHDF2-dependent
manner
inhibit
Our
confirmed
significant
aging
suggested
could
be
potential
therapeutic
target
for
osteoporosis.
Journal of Pineal Research,
Год журнала:
2024,
Номер
76(3)
Опубликована: Апрель 1, 2024
Abstract
Osteoporosis
(OP)
is
a
severe
global
health
issue
that
has
significant
implications
for
productivity
and
human
lifespan.
Gut
microbiota
dysbiosis
been
demonstrated
to
be
closely
associated
with
OP
progression.
Melatonin
(MLT)
an
important
endogenous
hormone
modulates
bone
metabolism,
maintains
homeostasis,
improves
Multiple
studies
indicated
MLT
participates
in
the
regulation
of
intestinal
gut
barrier
function.
However,
promising
effects
microbiota‐derived
remain
unclear.
Here,
we
found
resulted
tryptophan
disorder
decreased
production
MLT,
while
administration
could
mitigate
OP‐related
clinical
symptoms
reverse
dysbiosis,
including
diversity
microbiota,
relative
abundance
many
probiotics
such
as
Allobaculum
Parasutterella
,
metabolic
function
flora
amino
acid
nucleotide
energy
metabolism.
Notably,
significantly
increased
short‐chain
fatty
acids
trimethylamine
N‐oxide‐related
metabolites.
Importantly,
modulate
dynamic
balance
M1/M2
macrophages,
reduce
serum
levels
pro‐inflammatory
cytokines,
restore
gut‐barrier
Taken
together,
our
results
highlighted
roles
microbially
derived
progression
via
“gut‐bone”
axis
SCFA
which
may
provide
novel
insight
into
development
drug
treating
OP.
Journal of Nanobiotechnology,
Год журнала:
2023,
Номер
21(1)
Опубликована: Апрель 11, 2023
Osteoporosis
(OP)
is
a
metabolic
bone
disease
characterized
by
decreased
mass
and
increased
fragility.
The
imbalance
of
homeostasis
modulated
osteoclasts
osteoblasts
the
most
crucial
pathological
change
in
osteoporosis.
As
novel
treatment
strategy,
nanomedicine
has
been
applied
drug
delivery
targeted
therapy
due
to
its
high
efficiency,
precision,
fewer
side
effects.
Gold
nanospheres
(GNS),
as
common
kind
gold
nanoparticles
(GNPs),
possess
significant
antimicrobial
anti-inflammatory
activity,
which
have
for
eye
diseases
rheumatoid
arthritis.
However,
effect
GNS
on
osteoporosis
remains
elusive.
In
this
study,
we
found
that
significantly
prevented
ovariectomy
(OVX)-induced
gut
microbiota-dependent
manner.
16S
rDNA
gene
sequencing
demonstrated
markedly
altered
microbial
diversity
flora
composition.
addition,
reduced
abundance
TMAO-related
metabolites
OVX
mice.
Low
TMAO
levels
might
alleviate
loss
phenomenon
reducing
inflammation
response.
Therefore,
investigated
alteration
cytokine
profiles
inhibited
release
pro-osteoclastogenic
or
proinflammatory
cytokines
including
tumor
necrosis
factor
α
(TNF-α),
interleukin
(IL)-6,
granulocyte
colony-stimulating
(G-CSF)
serum.
conclusion,
suppressed
estrogen
deficiency-induced
regulating
destroyed
microbiota
so
reduce
relevant
metabolism
restrain
cytokines.
These
results
protective
effects
modulator
offered
insights
into
regulation
"gut-bone"
axis.
AJP Cell Physiology,
Год журнала:
2023,
Номер
324(5), С. C1089 - C1100
Опубликована: Март 7, 2023
The
objective
of
this
study
is
to
explore
the
specific
roles
a
crucial
N6-methyladenosine
(m6A)
methyltransferase,
methyltransferase-like
14
(METTL14),
in
fibroblast-like
synoviocytes
(FLSs)
activation
rheumatoid
arthritis
(RA).
RA
rat
model
was
induced
by
administering
intraperitoneally
collagen
antibody
alcohol.
Primary
were
isolated
from
joint
synovium
tissues
rats.
shRNA
transfection
tools
used
downregulate
METTL14
expression
vivo
and
vitro.
injury
shown
hematoxylin
eosin
(HE)
staining.
cell
apoptosis
FLSs
determined
flow
cytometry.
levels
IL-6,
IL-18,
C-X-C
motif
chemokine
ligand
(CXCL)10
serum
culture
supernatants
measured
ELISA
kits.
expressions
LIM
SH3
domain
protein
1
(LASP1),
p-SRC/SRC,
p-AKT/AKT
Western
blots.
greatly
rats
compared
with
normal
control
Compared
sh-NC-treated
FLSs,
knockdown
significantly
increased
apoptosis,
inhibited
migration
invasion,
suppressed
production
CXCL10
TNF-α.
silencing
suppresses
LASP1
Src/AKT
axis
TNF-α
FLSs.
improves
mRNA
stability
through
m6A
modification.
In
contrast,
these
reversed
overexpression.
Moreover,
clearly
alleviates
inflammation
model.
These
results
suggested
that
promotes
related
inflammatory
response
via
LASP1/SRC/AKT
signaling
pathway
identified
as
potential
target
for
treating
RA.
Journal of Translational Medicine,
Год журнала:
2024,
Номер
22(1)
Опубликована: Фев. 14, 2024
Abstract
Skeletal
system
disease
(SSD)
is
defined
as
a
class
of
chronic
disorders
skeletal
with
poor
prognosis
and
causes
heavy
economic
burden.
m6A,
methylation
at
the
N6
position
adenosine
in
RNA,
reversible
dynamic
modification
posttranscriptional
mRNA.
Evidences
suggest
that
m6A
modifications
play
crucial
role
regulating
biological
processes
all
kinds
diseases,
such
malignancy.
Recently
studies
have
revealed
most
abundant
epigentic
modification,
involved
progression
SSD.
However,
function
SSD
not
fully
illustrated.
Therefore,
make
clear
relationship
between
pathogenesis
might
provide
novel
sights
for
prevention
targeted
treatment
This
article
will
summarize
recent
advances
regulation
SSD,
including
osteoporosis,
osteosarcoma,
rheumatoid
arthritis
osteoarthritis,
discuss
potential
clinical
value,
research
challenge
future
prospect
Antioxidants,
Год журнала:
2024,
Номер
13(4), С. 470 - 470
Опубликована: Апрель 17, 2024
Imbalanced
osteogenic
cell-mediated
bone
gain
and
osteoclastic
remodeling
accelerates
the
development
of
osteoporosis,
which
is
leading
risk
factor
disability
in
elderly.
Harmonizing
metabolic
actions
bone-making
cells
resorbing
to
mineralized
matrix
network
required
maintain
mass
homeostasis.
The
tricarboxylic
acid
(TCA)
cycle
mitochondria
a
crucial
process
for
cellular
energy
production
redox
canonical
TCA
enzymes
intermediates
are
indispensable
oxidative
phosphorylation
adenosine
triphosphate
(ATP)
biosynthesis
differentiation
osteoclast
formation.
Knockout
mouse
models
identify
these
enzymes’
roles
microarchitecture.
In
noncanonical
processes,
metabolites
as
co-factor
or
substrate
involve
epigenetic
modification,
including
histone
acetyltransferases,
DNA
demethylases,
RNA
m6A
affect
genomic
stability
chromatin
accessibility
cell
metabolism
formation
resorption.
genetic
manipulation
regulators
intermediate
supplementation
compromises
age,
estrogen
deficiency,
inflammation-induced
loss
microstructure
deterioration.
This
review
sheds
light
on
functions
terms
integrity
highlights
crosstalk
pathways
skeletal
tissue
treatment
options
delaying
osteoporosis.
Journal of Orthopaedic Surgery and Research,
Год журнала:
2025,
Номер
19(1)
Опубликована: Янв. 4, 2025
Interactions
between
RNA-binding
proteins
and
RNA
regulate
transcription
during
osteoporosis.
Ferroptosis,
a
programmed
cell
death
caused
by
iron
metabolism,
plays
vital
role
in
However,
the
mechanisms
which
are
involved
ferroptosis
osteoporosis
remain
unclear.
We
established
an
vitro
model
of
induced
D-galactose
(D-gal)
MC3T3-E1
cells.
Ferroptosis
suppressor
protein
1
(FSP1),
activating
factor
4
(ATF4),
Y-box
binding
(YBX1)
knockdown
cells
were
generated,
their
effects
on
verified
measuring
lipid
reactive
oxygen
species
levels
cellular
Fe2+.
Chromatin
immunoprecipitation
luciferase
assays
performed
to
confirm
ATF4
FSP1
promoter.
pulldown
experiments
used
determine
YBX1
mRNA
test
effect
stability
5-methylcytosine
(m5C)-dependent
manner.
or
led
D-gal-induced
increase
Fe2+
cells,
was
alleviated
overexpression.
inhibits
In
addition,
increased
through
m5C
modification
inhibited
via
ATF4/FSP1
axis.
Our
results
showed
that
could
alleviate
axis
m5C-dependent
manner
osteoblasts,
suggesting
may
be
new
target
for
treatment.
Journal of Cellular and Molecular Medicine,
Год журнала:
2025,
Номер
29(1)
Опубликована: Янв. 1, 2025
ABSTRACT
Osteoporosis,
recognised
as
a
metabolic
disorder,
has
emerged
significant
burden
on
global
health.
Although
available
treatments
have
made
considerable
advancements,
they
remain
inadequately
addressed.
In
recent
years,
the
role
of
epigenetic
mechanisms
in
skeletal
disorders
garnered
substantial
attention,
particularly
concerning
m
6
A
RNA
modification.
is
most
prevalent
dynamic
and
reversible
modification
eukaryotes,
mediating
various
processes
mRNAs,
including
splicing,
structural
conversion,
translation,
translocation
degradation
serves
crucial
component
Research
increasingly
validated
that
plays
vital
proliferation,
differentiation,
migration,
invasion,and
repair
bone
marrow
mesenchymal
stem
cells
(BMSCs),
osteoblasts
osteoclasts,
all
which
impact
whole
process
osteoporosis
pathogenesis.
Continuous
efforts
been
to
target
regulators
natural
products
derived
from
traditional
medicine,
exhibit
multiple
biological
activities
such
anti‐inflammatory
anticancer
effects,
valuable
resources
for
drug
discovery.
This
paper
elaborates
methylation
its
regulatory
osteoporosis,
emphasising
implications
diagnosis
treatment,
thereby
providing
theoretical
references.
Cell Proliferation,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 17, 2025
ABSTRACT
Human
periodontal
ligament
stem
cells
(hPDLSCs)
have
emerged
as
promising
candidates
for
the
treatment
of
osteoporotic
bone
defects.
Previous
studies
indicated
that
m
6
A
plays
a
crucial
role
in
regulating
osteogenic
differentiation
hPDLSCs.
However,
research
on
relationship
between
YTHDC1,
reading
protein,
and
hPDLSCs
remains
unexplored.
This
study
aimed
to
investigate
biological
roles
YTHDC1
explore
underlying
mechanisms.
Dot
blot
analysis
revealed
progressive
increase
methylation
during
differentiation,
accompanied
by
significant
upregulation
expression,
evidenced
qPCR
Western
blot.
Functional
assays
utilising
siRNA‐mediated
knockdown
lentiviral‐mediated
overexpression
demonstrated
positively
regulated
potential
Mechanistically,
mRNA‐seq
implicated
Wnt/β‐catenin
signalling
pathway,
which
was
further
validated
through
rescue
experiments
with
Wnt
inhibitor
DKK1.
Notably,
vivo
showed
overexpressing
exhibited
enhanced
formation
capacity
rats.
In
conclusion,
our
findings
suggested
modulated
highlighting
its
therapeutic
treating
defects
conditions.